[EN] PYRIDAZIN-3 (2H) -ONE DERIVATIVES AND THEIR USE AS PDE4 INHIBITORS [FR] DERIVES DE PYRIDAZINE-3(2H)-ONES ET UTILISATION EN TANT QU'INHIBITEURS DE PDE4
[EN] PYRIDAZIN-3(2H)-ONE DERIVATIVES AS PDE4 INHIBITORS<br/>[FR] DERIVES DE LA PYRIDAZINE-3(2h)-ONE, INHIBITEURS DE LA PDE4
申请人:ALMIRALL PRODESFARMA SA
公开号:WO2003097613A1
公开(公告)日:2003-11-27
New pyridazin-3(2H)-one derivatives having the chemical structure of general formula (I); are disclosed; as well as processes for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of phosphodiesterase 4.
Pyridazin-3(2h)-one derivatives as pde4 inhibitors
申请人:Dal Piaz Vittorio
公开号:US20060052379A1
公开(公告)日:2006-03-09
New pyridazin-3(2H)-one derivatives having the chemical structure of general formula (I) are disclosed; as well as process for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of phosphodiesterase 4.
PYRIDAZIN-3 (2H) -ONE DERIVATIVES AS PDE4 INHIBITORS
申请人:Dal Piaz Vittorio
公开号:US20080269235A1
公开(公告)日:2008-10-30
New pyridazin-3(2H)-one derivatives having the chemical structure of general formula (I) are disclosed; as well as process for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of phosphodiesterase 4.
Pyridazin-3(2)-one derivatives and their use as pde4 inhibitors
申请人:Dal Piaz Vittorio
公开号:US20070197536A1
公开(公告)日:2007-08-23
New pyridazin-e-(2H)-one derivatives having the chemical structure of general formula (I) are disclosed; as well as processes for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of phosphodiesterase 4.
Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors
申请人:Laboratorios Almirall S.A.
公开号:US07511038B2
公开(公告)日:2009-03-31
New pyridazin-e-(2H)-one derivatives having the chemical structure of general formula (I) are disclosed; as well as processes for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of phosphodiesterase 4.